What is AbbVie Inc's current stock price?

View AbbVie Inc (ABBV)'s real-time stock price, AI-powered analysis, and key financial metrics on Helm Terminal.

Is ABBV a good stock to buy?

ABBV analysis includes AI-driven insights covering fundamentals, analyst consensus, and market sentiment. Visit Helm Terminal for the full breakdown.

What is AbbVie Inc's market cap?

Get AbbVie Inc's current market capitalization, P/E ratio, and other key financial metrics with Helm Terminal's free stock analysis tool.

Where can I get free stock analysis for ABBV?

Helm Terminal offers free AI-powered stock analysis for ABBV, including financial summaries, key metrics, and market insights at helmterminal.dev/analyze/ABBV.

ABBV Stock Analysis — Helm Terminal

← Back to search

ABBVNeutral

AbbVie Inc

Helm AI

AbbVie Inc (ABBV) trades at $211.59, reflecting a market cap of $374.13B, but with a high P/E ratio of 86.27, the stock appears overvalued despite its revenue growth of 8.57% year-over-year. The current dividend yield of 3.27% is attractive, yet the negative EPS growth of -1.30% raises concerns about future profitability. Analyst consensus has 7 Strong Buy and 21 Buy ratings, indicating potential support for the stock.

Current Price

$211.59

+2.53%vs previous close

Market Cap

$374.13B

P/E Ratio

86.27

Revenue Growth YoY

8.57%

Dividend Yield

3.27%

EPS Growth YoY

-1.30%

Recommendation

Hold ABBV for now, given mixed signals from growth metrics and valuation concerns.

Recent Headlines

Sector Update: Health Care Stocks Advance Late Afternoon

2026-04-08

Why The AbbVie (ABBV) Story Is Shifting As Immunology Hopes Meet Valuation Doubts

2026-04-08

AbbVie Sues to Narrow Definition of Eligible Patients in US Drug Discount Program

2026-04-08

3 Absurdly Cheap Dividend Stocks to Buy in April 2026

2026-04-08